Previous close | 3.4718 |
Open | 3.3786 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 3.3786 - 3.4280 |
52-week range | 1.8858 - 4.5000 |
Volume | |
Avg. volume | 18,316 |
Market cap | 801.37M |
Beta (5Y monthly) | 1.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1100 |
Earnings date | 09 May 2023 - 15 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its audited consolidated financial results for the fiscal year and fourth quarter ended December 31, 2022.
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the Company will release its Fiscal Fourth Quarter and Year End 2022 financial results for the period ended December 30, 2022, on Tuesday, March 21, 2023. The Company will hold a conference call and simultaneous webcast to discus
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (Frankfurt: W7V.F) ("WELL" or the "Company"), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce it has made a strategic investment, through its wholly owned subsidiary, WELL Ventures, in doctorly GmbH ("doctorly"), a medical practice management software provider based in Germany. WELL Ventures is investing as part of a synd